tradingkey.logo

Korro Bio Inc

KRRO

33.220USD

+2.840+9.35%
Close 09/18, 16:00ETQuotes delayed by 15 min
311.96MMarket Cap
LossP/E TTM
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
Total revenue
--1.46M
--2.55M
--2.27M
----
----
----
Revenue
--1.46M
--2.55M
--2.27M
----
----
----
Operating expenses
18.81%28.66M
28.51%27.57M
--25.31M
--23.29M
--24.13M
--21.45M
R&D expenses
22.72%21.03M
45.44%19.74M
--16.96M
--15.96M
--17.14M
--13.57M
Depreciation, depletion, and amortization
70.18%1.23M
68.73%1.23M
--1.30M
--900.00K
--721.00K
--726.00K
Operating profit
-12.75%-27.20M
-16.63%-25.02M
---23.04M
---23.29M
---24.13M
---21.45M
Net non-operating interest income (expenses)
Other non-operating income (expenses)
-38.47%1.43M
-14.64%1.63M
--1.94M
--2.28M
--2.33M
--1.91M
Income before tax
-18.23%-25.77M
-19.69%-23.39M
---21.10M
---21.01M
---21.80M
---19.54M
Income tax
-96.67%1.00K
-100.00%0.00
--103.00K
---9.00K
--30.00K
--17.00K
Income after tax
-18.07%-25.77M
-19.58%-23.39M
---21.20M
---21.00M
---21.83M
---19.56M
Net income from continuous operations
-18.07%-25.77M
-19.58%-23.39M
---21.20M
---21.00M
---21.83M
---19.56M
Net income attributable to controlling interests
-18.07%-25.77M
-19.58%-23.39M
---21.20M
---21.00M
---21.83M
---19.56M
Net income attributable to common shareholders
-18.07%-25.77M
-19.58%-23.39M
---21.20M
---21.00M
---21.83M
---19.56M
Basic earnings per share
-12.99%-2.74
-2.19%-2.49
---2.26
---2.26
---2.43
---2.44
Diluted earnings per share
-12.99%-2.74
-2.19%-2.49
---2.26
---2.26
---2.43
---2.44
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
KeyAI